Your browser doesn't support javascript.
loading
Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004-2013.
Mauro, Christine M; Newswanger, Paul; Santaella-Tenorio, Julian; Mauro, Pia M; Carliner, Hannah; Martins, Silvia S.
Afiliación
  • Mauro CM; Department of Biostatistics, Columbia University, New York, NY, USA. cmm2212@cumc.columbia.edu.
  • Newswanger P; Department of Sociomedical Sciences, Columbia University, New York, NY, USA.
  • Santaella-Tenorio J; Department of Epidemiology, Columbia University, New York, NY, USA.
  • Mauro PM; Department of Epidemiology, Columbia University, New York, NY, USA.
  • Carliner H; Department of Epidemiology, Columbia University, New York, NY, USA.
  • Martins SS; New York State Psychiatric Institute, New York, NY, USA.
Prev Sci ; 20(2): 205-214, 2019 02.
Article en En | MEDLINE | ID: mdl-29103076
In states that have passed medical marijuana laws (MMLs), marijuana use (MU) increased after MML enactment among people ages 26 and older, but not among ages 12-25. We examined whether the age-specific impact of MMLs on MU varied by gender. Data were obtained from the 2004-2013 restricted-use National Survey on Drug Use and Health, aggregated at the state level. The exposure was a time-varying indicator of state-level MML (0 = No Law, 1 = Before Law, 2 = After Law). Outcomes included past-month MU prevalence, daily MU prevalence among past-year users (i.e., 300+ days/year), and past-year marijuana use disorder (MUD) prevalence. Linear models tested the state-level MML effect on outcomes by age (12-17, 18-25, 26+) and gender. Models included a state-level random intercept and controlled for time- and state-level covariates. Past-month MU did not increase after enactment of MML in men or women ages 12-25. Among people 26+, past-month MU increased for men from 7.0% before to 8.7% after enactment (+ 1.7%, p < 0.001) and for women from 3.1% before to 4.3% after enactment (+ 1.1%, p = 0.013). Among users 26+, daily MU also increased after enactment in both genders (men 16.3 to 19.1%, + 2.8%, p = 0.014; women 9.2 to 12.7%, + 3.4%, p = 0.003). There were no statistically significant increases in past-year MUD prevalence for any age or gender group after MML enactment. Given the statistically significant increase in daily use among past-year users aged 26+ following enactment, education campaigns should focus on informing the public of the risks associated with regular marijuana use.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Peloideterapia / Plantas_medicinales Asunto principal: Fumar Marihuana / Marihuana Medicinal / Uso de la Marihuana / Legislación de Medicamentos Tipo de estudio: Prevalence_studies País/Región como asunto: America do norte Idioma: En Revista: Prev Sci Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Peloideterapia / Plantas_medicinales Asunto principal: Fumar Marihuana / Marihuana Medicinal / Uso de la Marihuana / Legislación de Medicamentos Tipo de estudio: Prevalence_studies País/Región como asunto: America do norte Idioma: En Revista: Prev Sci Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos